Results 171 to 180 of about 22,475 (211)
Reactions Weekly, 2023 Using ondansetron in gastroenteritis with ...
Rang Ngoc Nguyen (9039692)
core +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
European Journal of Cancer, 1993
Ondansetron is the first selective antagonist of the 5-hydroxytryptamine receptors (type 3) marketed for the prevention of emesis induced by antineoplastic agents. Ondansetron has been shown to be more active and less toxic than high-dose metoclopramide in patients submitted to cisplatin chemotherapy.
F, Roila +8 more
+6 more sources
Ondansetron is the first selective antagonist of the 5-hydroxytryptamine receptors (type 3) marketed for the prevention of emesis induced by antineoplastic agents. Ondansetron has been shown to be more active and less toxic than high-dose metoclopramide in patients submitted to cisplatin chemotherapy.
F, Roila +8 more
+6 more sources
Acta Obstetricia Et Gynecologica Scandinavica, 2007 BACKGROUND: Postoperative pruritus, nausea, and vomiting are common side effects of intrathecal or epidural opioids. Intravenous ondansetron has been used for postoperative emesis. However, there are no reports regarding epidural ondansetron.
Dong Woo Han, Ki Jun Kim
exaly +2 more sources
Fatal anaphylaxis to intravenous ondansetron: A case report
Clinical Case Reports (discontinued), 2021Kalyan Sapkota
exaly